Centers for Excellence
Drs. Barry Leshin & Glenn Goldman
Healthcare is rapidly changing as third-party payers move towards value-based care. To meet this change, it behooves our organization leadership to help our field define the value of the care we deliver to our patients and within the medical profession. One way of doing so is by creating Centers of Excellence, which are specialized programs that deliver expertise in a comprehensive and exceptional manner. Our project aims to define the components of such Centers from organizational design, service design, personnel, medical care, marketing, and finance. The Delphi method will be utilized to survey ACMS members in both academic and private settings to identify metrics that define excellence in Mohs surgery. We hope to identify minimum qualifying clinical benchmarks and describe a tiered system that will allow fellowship-trained Mohs surgeons to be recognized for their excellence. Potential data sources include MohsAIQ, CMS claims data, and published data, each with its limitations. The project is under the direct sponsorship of ACMS past presidents Dr. Glenn Goldman and Dr. Barry Leshin.
Lindsey Collins, MD is the Director of Micrographic Surgery and Dermatologic Oncology at the University of Oklahoma Health Sciences Center and an Assistant Professor in the College of Medicine. Prior to joining the faculty in the Department of Dermatology in 2017, Dr. Collins attended medical school at the University of Arkansas for Medical Sciences in Little Rock, AR. Following medical school, she completed her dermatology residency at Dartmouth-Hitchcock Medical Center in Hanover, NH, and then completed a fellowship in Mohs Micrographic Surgery and Dermatologic Oncology at the University of Vermont in Burlington, VT. Dr. Collins specializes in Mohs micrographic surgery, cosmetic dermatology, and high-risk skin cancers. Her primary scholarly interests include outcomes in non-melanoma skin cancer, optimizing outcomes in Mohs micrographic surgery, skin cancer reconstruction, and transplant dermatology. When not at work, you can find Dr. Collins on the golf course working on her game.
Hao Feng, MD is a board-certified dermatologist who practices Mohs surgery, laser surgery, and cosmetic dermatology. He practices at the University of Connecticut Health Center, where he is an Assistant Professor and Director of Laser Surgery and Cosmetic Dermatology. Dr. Feng earned his medical degree from Yale University School of Medicine, where he was awarded the Doris Duke Clinical Research Fellowship. He completed his Dermatology Residency at New York University The Ronald O. Perelman Department of Dermatology, where he was Chief Resident and awarded the George R. Lipkin, M.D. Prize and the Maurice Husik Research Prize in recognition of clinical excellence and research productivity. He pursued his fellowship training in Mohs surgery, laser surgery, and cosmetic dermatology at Laser & Skin Surgery Center of New York. Dr. Feng has extensive leadership experience and involvement in advocacy and organized medicine. His research interests and efforts have been focused on procedural dermatology, healthcare delivery and policy, dermatologic health disparities, and ethical issues in dermatology.
Nour Kibbi, MD is a Clinical Assistant Professor of dermatology and dermatologic surgery at Stanford University. She completed her dermatology residency and dermatologic surgery fellowship at Yale University. In addition to Mohs surgery, she performs laser treatments and other aesthetic procedures for photodamage. Her academic interests include rare tumors, actinic damage, laser therapy, scarring, and medical education. She is the director of resident dermatologic surgery education. She serves as Section Editor for the British Journal of Dermatology and Associate Editor for the Journal of Dermatologic Therapy. As a California transplant, she lives in Palo Alto with her husband and 7-month-old daughter.
ACMS Diversity Mentorship Program
Dr. Ken Neal
There is growing evidence that increasing diversity and improving cultural awareness, equity, and inclusion leads to improvements in the quality of physician-patient relationships as well as patient outcomes. Lack of diversity has been highlighted in Dermatology as a specialty, Micrographic Surgery and Dermatologic Oncology (MSDO) as a subspecialty, and in the membership and leadership of the American College of Mohs Surgery (ACMS). Our team has identified 3 major areas for potential action, with the goal of promoting the continued growth of URM in the MSDO/ACMS long-term: 1) education and cultural awareness 2) holistic review of MSDO fellowship candidates, and 3) mentorship. Our 2021-2022 project will focus on improving the pipeline for underrepresented minority in medicine (URM) residents through a formal mentorship program. Working in collaboration with the ACMS Diversity Task Force, our team aims to launch the ACMS Diversity Mentorship Program in 2022. This program will provide URM dermatology residents the opportunity to build relationships with ACMS mentors who can provide career guidance, research collaboration, as well as visiting internships.
Julia Baltz, MD received a BA in English Literature from the College of William and Mary followed by her medical degree at the University of North Dakota School of Medicine. She completed an internal medicine internship at the University of Virginia followed by a Dermatology residency at the University of Massachusetts. Dr. Baltz completed a fellowship in Mohs Micrographic Surgery and Cutaneous Oncology with an emphasis on nail surgery under the direction of Dr. Nathaniel Jellinek. Her areas of interest include nail surgery as well as complex reconstruction.
Naiara Barbosa, MD Originally from Brazil, Dr. Naiara Barbosa received her MD from the University of Vermont College of Medicine and completed her Dermatology residency and Micrographic Surgery and Dermatologic Oncology fellowship at Mayo Clinic in Rochester, MN. Dr. Barbosa joined the University of New Mexico faculty in July 2018. She serves as Director of Mohs Surgery and Dermatologic Oncology and Director of Diversity, Equity, and Inclusion. Her clinical areas of expertise include diagnosis and treatment of all skin cancers, procedural dermatology, and skin surveillance in immunosuppressed patients. Dr. Barbosa's academic interests include melanoma and squamous cell carcinoma research, health care disparities, and diversity/inclusion advocacy and mentorship.
Nahid Y. Vidal, MD, FAAD, FACMS is a refugee immigrant of Afghanistan descent who grew up in Ventura, California. She received her Bachelor’s from Stanford in Human Biology with a concentration on physics and human performance. Nahid completed medical school and internship at University California Davis, followed by a dermatology residency at the University of Iowa. After completing a fellowship in Micrographic Surgery and Dermatologic Oncology at Mayo Clinic, Nahid joined Dartmouth-Hitchcock where she served as Director of Dermatologic Surgery and Director of Surgical Education. She returned to Mayo Clinic in Rochester, Minnesota in the fall of 2019 and currently serves as Director of resident dermatologic surgery education and Chair for the Division of Dermatologic Surgery. She has a passion for the management of rare and complex cutaneous malignancies and complex facial reconstruction and has academic interests in immunohistochemistry, artificial intelligence/machine learning, and innovation in education. As a former water polo player, Nahid considers herself a sports enthusiast (especially basketball) but also enjoys good food and stand-up comedy. In her free time, she can be found chasing her (really fast) son Mogey, or binge-watching TV with her husband.
John G. Albertini, MD, FACMS has practiced at The Skin Surgery Center in NC since 2002, following active duty in the Air Force. Dr. Albertini served as surgical faculty and later as fellowship director of an ACMS and ACGME approved training program in Mohs surgery and Procedural Dermatology from 2002-2013. He currently helps train residents as a volunteer associate professor at Wake Forest University Department of Plastic and Reconstructive Surgery. Dr. Albertini is a past president of the NC Dermatology Association and the American College of Mohs Surgery, having served on the Board of Directors and as member and chair of numerous committees, including currently the Improving Wisely program. He is a frequent lecturer and author on appropriate and quality care, Mohs surgery, and advanced reconstruction.
Ian Maher, MD, FACMS Dr. Maher is a professor, Director of Dermatology, and Mohs Fellowship Director at the University of Minnesota. He is a nationally recognized expert in the field of Mohs surgery and facial reconstruction. His research focuses on outcome measurement and the development of new reconstructive techniques.
Mary Maloney, MD, FACMS is the retired Chair and Professor of Dermatology at the University of Massachusetts where she continues to practice Mohs surgery. She received her medical degree from the University of Vermont, completed her residency at Dartmouth, and her fellowship at the University of California in San Francisco. Dr. Maloney has been active in leadership development with the AAD and has been an active mentor with the AAD, ACMS, and WDS. Interests include leadership, ethics and professionalism, climate change and dermatology, cutaneous oncology, and equity in health care.
Christopher J. Miller, MD, FACMS is a Professor of Dermatology and the Director of the Penn Dermatology Oncology Center at the Hospital of the University of Pennsylvania. He earned his medical degree at Jefferson Medical College of Thomas Jefferson University in 2000 and his bachelor's at the University of Notre Dame in 1996. Dr. Miller’s clinical practice focuses on the use of Mohs micrographic surgery and reconstructive surgery to treat patients with skin cancers, particularly melanomas of the head and neck and advanced tumors. He supplements his clinical practice with research concentrating on the clinical and epidemiologic aspects of various skin cancers. Dr. Miller’s recent research evaluates the efficacy of Mohs surgery for melanomas of the head and neck and advanced reconstructive surgery techniques. He also continues to investigate his special interests in advanced techniques of Mohs micrographic surgery, dermatologic surgery education, and service excellence in health care delivery.
Kishwer S. Nehal, MD, FACMS is a graduate of Boston University School of Medicine and she completed her Dermatology residency and Mohs fellowship at New York University. Dr. Nehal joined Memorial Sloan Kettering Cancer Center (MSKCC) in New York City in 1998 and developed the skin cancer surgery program. She is currently the Director of Mohs and Dermatologic Surgery and Attending Physician at MSKCC and Professor of Dermatology at Weill Cornell. Dr. Nehal leads the Multidisciplinary Skin Cancer Management Program at MSKCC providing comprehensive care for patients with high risk, complex, and advanced skin cancers in a multidisciplinary setting. Dr. Nehal serves on the National Comprehensive Cancer Network panel for nonmelanoma skin cancers and development of clinical practice guidelines. She has also served on the American Joint Committee on Cancer expert panel to develop staging for cutaneous squamous cell carcinoma. Her clinical research in noninvasive imaging in collaboration with the optical imaging team at MSKCC has led to advances in real-time skin cancer imaging to guide surgery. She has published extensively on cutaneous oncology including lentigo maligna melanoma and is the author of 137.
Ashley Wysong, MD, MS, FACMS is the University of Nebraska Department of Dermatology Founding Chair and William W. Bruce MD Distinguished Chair of Dermatology. She also serves as the Director of the Skin Cancer Program at the Fred & Pamela Buffett Cancer Center and Chief of Dermatology at the Nebraska-Western Iowa Veterans Health Care System. Dr. Wysong is a cancer epidemiologist and translational scientist with a special interest and expertise in locally advanced non-melanoma skin cancer, as well as the treatment of rare skin tumors. She serves as a member of the ACMS Board of Directors and the Chair of the 2022 ACMS Annual Meeting and Scientific Advisory Committee.